We report the case of who has been hospitalized complaining about fever in the last 4 days. Laboratory data revealed lymphocytopenia and leucopenia with an elevation of C-reactive protein and positive real-time reverse transcription-polymerase chain reaction (RT-PCR). Six days before this hospitalization, when the patient was asymptomatic, 18F-FDG PET/CT images were performed for the therapeutic control of liver metastases of colorectal cancer. Lung abnormality findings at 18F-FDG PET/CT images, unrelated to cancer metastases, but suspicious for viral infection, may suggest the presence of COVID-19 disease in its early phase before symptoms onset. Since PET/CT is more sensitive than CT scan in detecting host’s reaction, the added value of this technique could be monitoring disease progression and could be used as a biomarker of lung disease activity and therefore as an important tool for a better understanding of the factors that contribute to the progression of lung disease.

Early 18F-FDG PET/CT in COVID-19 / Cosma, L.; Sollaku, S.; Frantellizzi, V.; De Vincentis, G.. - In: JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY. - ISSN 1754-9477. - (2020), pp. 671-673. [10.1111/1754-9485.13099]

Early 18F-FDG PET/CT in COVID-19

Cosma L.
Primo
;
Sollaku S.
Secondo
;
Frantellizzi V.
;
De Vincentis G.
Ultimo
2020

Abstract

We report the case of who has been hospitalized complaining about fever in the last 4 days. Laboratory data revealed lymphocytopenia and leucopenia with an elevation of C-reactive protein and positive real-time reverse transcription-polymerase chain reaction (RT-PCR). Six days before this hospitalization, when the patient was asymptomatic, 18F-FDG PET/CT images were performed for the therapeutic control of liver metastases of colorectal cancer. Lung abnormality findings at 18F-FDG PET/CT images, unrelated to cancer metastases, but suspicious for viral infection, may suggest the presence of COVID-19 disease in its early phase before symptoms onset. Since PET/CT is more sensitive than CT scan in detecting host’s reaction, the added value of this technique could be monitoring disease progression and could be used as a biomarker of lung disease activity and therefore as an important tool for a better understanding of the factors that contribute to the progression of lung disease.
2020
18; F-FDG PET/CT; COVID-19; infection lung; lymphadenopathy; SARS-CoV-2
01 Pubblicazione su rivista::01i Case report
Early 18F-FDG PET/CT in COVID-19 / Cosma, L.; Sollaku, S.; Frantellizzi, V.; De Vincentis, G.. - In: JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY. - ISSN 1754-9477. - (2020), pp. 671-673. [10.1111/1754-9485.13099]
File allegati a questo prodotto
File Dimensione Formato  
Cosma_Early_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 649.73 kB
Formato Adobe PDF
649.73 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1439987
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 6
social impact